Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report

Epidermal growth factor receptor (EGFR) exon 20 insertion is not associated with sensitivity to EGFR tyrosine kinase inhibitors and chemotherapy. Here, we report the case of a 41-year-old man who presented a right lower lobe nodule and mediastinal lymph node enlargement diagnosed as EGFR exon 20 ins...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Med Case Rep
Autors principals: Matsuura, Shun, Morikawa, Keisuke, Ito, Yutaro, Kagoo, Namio, Kubota, Tsutomu, Ichijo, Koshiro, Mochizuki, Eisuke, Uehara, Masahiro, Harada, Masanori, Tsukui, Masaru, Koshimizu, Naoki
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552097/
https://ncbi.nlm.nih.gov/pubmed/33083220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101236
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars